New Insights into the Role of NLRP3 Inflammasome in Pathogenesis and Treatment of Chronic Obstructive Pulmonary Disease
Jie Zhang,1,2,* Qiuyun Xu,1,* Weichen Sun,1,* Xiaorong Zhou,1 Da Fu,3 Liming Mao1,4 1Department of Immunology, School of Medicine, Nantong University, Nantong, Jiangsu, 226019, People’s Republic of China; 2Affiliated Hospital of Nantong University, Nantong, Jiangsu, 226019, P...
Guardado en:
Autores principales: | Zhang J, Xu Q, Sun W, Zhou X, Fu D, Mao L |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/95a114a879b94c4e91f9be6e137c7f50 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Spotlight on the NLRP3 inflammasome pathway
por: Groslambert M, et al.
Publicado: (2018) -
Activation and Inhibition of the NLRP3 Inflammasome by RNA Viruses
por: Choudhury SM, et al.
Publicado: (2021) -
In vitro expression of NLRP inflammasome-induced active Caspase-1 expression in normal human epidermal keratinocytes (NHEK) by various exogenous threats and subsequent inhibition by naturally derived ingredient blends
por: Gruber JV, et al.
Publicado: (2019) -
Epac1 inhibits PKR to reduce NLRP3 inflammasome proteins in retinal endothelial cells
por: Jiang Y, et al.
Publicado: (2019) -
Mangiferin Mitigates Lipopolysaccharide-Induced Lung Injury by Inhibiting NLRP3 Inflammasome Activation
por: Li N, et al.
Publicado: (2021)